Standardized alkali-treated Euglena gracilis β-glucan mitigates PM2.5-induced pulmonary and cerebral injury through NF-κB, NRF2, and CREB–BDNF–TrkB pathways

Key Points

• Treatment with alkali-treated euglena gracilis beta-glucan reduces pulmonary and cerebral injury.
• Key pathways involved include nf-kb, nrf2, and creb-bdnf-trkb, crucial for protecting brain and lung health.
• Analysis involved experimental intervention using standardized euglena gracilis beta-glucan to assess impact on injury.
• Findings suggest this approach may enhance therapeutic strategies for PM2.5-related health issues.